Sumitomo Mitsui Trust Group
SRTA icon

Sumitomo Mitsui Trust Group’s Strata Critical Medical Inc SRTA Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1,052,611
Closed -$5.55M – 1065
2026
Q2 		$5.55M Sell
1,052,611
-601,750
-36% -$3.17M ﹤0.01% 714
2026
Q1 		$6.92M Sell
1,654,361
-23,187
-1% -$112K ﹤0.01% 696
2025
Q4 		$8.07M Sell
1,677,548
-151,073
-8% -$731K ﹤0.01% 698
2025
Q3 		$9.25M Sell
1,828,621
-1,170,571
-39% -$5.17M 0.01% 687
2025
Q2 		$12.1M Hold
2,999,192
– – 0.01% 660
2025
Q1 		$8.19M Sell
2,999,192
-101,481
-3% -$364K 0.01% 705
2024
Q4 		$13.2M Sell
3,100,673
-659,089
-18% -$2.51M 0.01% 688
2024
Q3 		$11.1M Sell
3,759,762
-300,520
-7% -$957K 0.01% 704
2024
Q2 		$14.1M Buy
4,060,282
+381,308
+10% +$1.27M 0.01% 683
2024
Q1 		$10.5M Sell
3,678,974
-295,318
-7% -$911K 0.01% 763
2023
Q4 		$14M Sell
3,974,292
-285,969
-7% -$821K 0.01% 744
2023
Q3 		$11M Sell
4,260,261
-264,831
-6% -$930K 0.01% 770
2023
Q2 		$17.8M Sell
4,525,092
-257,547
-5% -$817K 0.01% 726
2023
Q1 		$16.2M Sell
4,782,639
-58,776
-1% -$240K 0.01% 741
2022
Q4 		$17.3M Sell
4,841,415
-32,366
-0.7% -$138K 0.01% 736
2022
Q3 		$19.6M Sell
4,873,781
-53,754
-1% -$276K 0.02% 701
2022
Q2 		$22M Buy
+4,927,535
New +$35.6M 0.02% 704
2022
Q1 		– Sell
-4,332,774
Closed -$38.3M – 1184
2021
Q4 		$38.3M Buy
4,332,774
+1,110,780
+34% +$10.6M 0.02% 616
2021
Q3 		$33.5M Buy
3,221,994
+1,575,574
+96% +$13.8M 0.02% 636
2021
Q2 		$17.3M Buy
1,646,420
+711,464
+76% +$7.02M 0.01% 742
2021
Q1 		$9.6M Buy
934,956
+919,355
+5,893% +$12.8M 0.01% 786
2020
Q4 		$173K Buy
+15,601
New +$159K ﹤0.01% 1110

Other funds holding SRTA

Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Creek Drive Management Group
Creek Drive Management Group San Francisco, California $368M AUM 23.05% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Sumitomo Mitsui Trust Group's SRTA Position: Q3 2026 in Review

Sumitomo Mitsui Trust Group sold out of Strata Critical Medical Inc (SRTA) in Q3 2026, closing a stake of 1,052,611 shares — an estimated $5.55M sold.

Sumitomo Mitsui Trust Group first reported a position in SRTA in Q4 2020 and held it in 22 quarters. The position peaked at $38.3M in Q4 2021. 75 funds tracked by Wall St. Rank hold SRTA as of Q3 2026.

  • Sumitomo Mitsui Trust Group reported no remaining Strata Critical Medical Inc position as of Q3 2026 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 1,052,611 Strata Critical Medical Inc shares in Q3 2026, an estimated $5.55M.
  • Sumitomo Mitsui Trust Group first reported a position in Strata Critical Medical Inc in Q4 2020 and held it in 22 quarters.
  • Sumitomo Mitsui Trust Group's Strata Critical Medical Inc position peaked at $38.3M in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2026, filed 29 Oct 2026.